In Search of Clinical Biomarkers of Response to Checkpoint Inhibitor Therapy in Renal Cell Carcinoma

被引：1
|
作者：
Fan, Alice C. [2 ]
Leppert, John T. [1 ]
机构：
[1] Stanford Univ, Dept Urol, Sch Med, 300 Pasteur Dr,Grant S-287, Stanford, CA 94305 USA
[2] Stanford Univ, Div Oncol, Dept Med, Sch Med, Stanford, CA 94305 USA
来源：
JAMA NETWORK OPEN | 2021年 / 4卷 / 01期
关键词：
D O I：
10.1001/jamanetworkopen.2020.35120
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：2
相关论文
共 50 条
  • [31] Combination VEGFR/immune checkpoint inhibitor therapy: a promising new treatment for renal cell carcinoma
    Chung-Han Lee
    Robert Motzer
    British Journal of Cancer, 2018, 119 : 911 - 912
  • [32] Immune Checkpoint Inhibitor Therapy Before Nephrectomy for Locally Advanced and Metastatic Renal Cell Carcinoma
    Ghoreifi, Alireza
    Vaishampayan, Ulka
    Yin, Ming
    Psutka, Sarah P.
    Djaladat, Hooman
    JAMA ONCOLOGY, 2024, 10 (02) : 240 - 248
  • [33] COMPLETE PATHOLOGICAL RESPONSE IN PATIENTS UNDERGOING NEPHRECTOMY FOR RENAL CELL CARCINOMA FOLLOWING IMMUNE CHECKPOINT INHIBITOR THERAPY: A MULTICENTER STUDY
    Ghoreifi, Alireza
    Gerald, Thomas
    Cheaib, Joseph
    Yerrapragada, Anirudh
    Cai, Jie
    Duddalwar, Vinay
    Gill, Inderbir
    Singla, Nirmish
    Margulis, Vitaly
    Djaladat, Hooman
    JOURNAL OF UROLOGY, 2023, 209 : E723 - E723
  • [34] BIOMARKERS OF SUNITNIB CLINICAL RESPONSE IN METASTATIC RENAL CLEAR CELL CARCINOMA PATIENTS
    Bastien, L.
    Paule, B.
    Maille, P.
    Azoulay, S.
    Allory, Y.
    Patard, J. J.
    Rioux-Leclercq, N.
    Crepel, M.
    Wallerand, H.
    Bernhard, J. C.
    Game, X.
    Mazerolles, C.
    Guillotreau, J.
    Ruffion, A.
    Decaussin-Petrucci, M.
    Zini L.
    Leroy, X.
    Berthon, N.
    Culine, S.
    Salomon, L.
    Hoznek, A.
    Vordos, D.
    Abbou, C. C.
    Mourah, S.
    De La Taille, A.
    EUROPEAN UROLOGY SUPPLEMENTS, 2009, 8 (04) : 298 - 298
  • [35] Biomarkers in metastatic renal cell carcinoma in the era of immune checkpoint inhibitors
    Tripathi, Abhishek
    Lin, Edwin
    Agarwal, Neeraj
    ANNALS OF TRANSLATIONAL MEDICINE, 2019, 7
  • [36] Immune checkpoint inhibitor-based therapy for advanced clear cell renal cell carcinoma: A narrative review
    Liu, Yi-Fu
    Zhang, Zhi-Cheng
    Wang, Si-Yuan
    Fu, Sheng-Qiang
    Cheng, Xiao-Feng
    Chen, Ru
    Sun, Ting
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2022, 110
  • [37] Circulating immune cell biomarkers predict response to immune checkpoint inhibitor therapy in metastatic breast cancer
    Bitar, Jin Sun
    Egelston, Colt
    Yost, Susan
    Hou, Wanqiu
    Simran, Padam
    Frankel, Paul
    Sedrak, Mina
    Portnow, Jana
    Mortimer, Joanne
    Yeon, Christina
    Hurria, Arti
    Tang, Aileen
    Martinez, Norma
    Lee, Peter
    Yuan, Yuan
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2019, 7
  • [38] SPATIAL MAPPING OF T CELL RECEPTORS AND TRANSCRIPTOMES IN RENAL CELL CARCINOMA FOLLOWING IMMUNE CHECKPOINT INHIBITOR THERAPY
    Liu, Sophia
    Iorgulescu, Bryan
    Li, Shuqiang
    Morriss, Julia
    Borji, Mehdi
    Murray, Evan
    Braun, David
    Livak, Kenneth
    Wu, Catherine
    Chen, Fei
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2021, 9 : A84 - A85
  • [39] Immune Checkpoint Inhibitor Therapy for Periocular Merkel Cell Carcinoma
    Hohlbein, Joshua
    Fan, Janet
    Goldberg, Hila
    Lu, Tracy
    Maniakas, Anastasios
    Wong, Michael
    Esmaeli, Bita
    OPHTHALMOLOGY, 2025, 132 (01) : 121 - 123
  • [40] Immune Checkpoint Therapy and the Search for Predictive Biomarkers
    Sharma, Padmanee
    CANCER JOURNAL, 2016, 22 (02): : 68 - 72
12345